FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4901411000001103: Aluminium hydroxide 500mg / Dimeticone 270mg chewable tablets 24 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22765701000001110 Aluminium hydroxide 500mg / Dimeticone 270mg chewable tablets 24 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40876801000001113 Aluminium hydroxide 500mg / Simeticone 270mg chewable tablets 24 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aluminium hydroxide 500mg / Dimeticone 270mg chewable tablets 24 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Aluminium hydroxide 500mg / Dimeticone 270mg chewable tablets 24 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Aluminium hydroxide 500mg / Dimeticone 270mg chewable tablets 24 tablet Is pack of Aluminium hydroxide 500mg / Dimeticone 270mg chewable tablets false Inferred relationship Existential restriction modifier
Aluminium hydroxide 500mg / Dimeticone 270mg chewable tablets 24 tablet Has active ingredient Dimeticone false Inferred relationship Existential restriction modifier
Aluminium hydroxide 500mg / Dimeticone 270mg chewable tablets 24 tablet Has active ingredient Aluminium hydroxide gel dried false Inferred relationship Existential restriction modifier
Aluminium hydroxide 500mg / Dimeticone 270mg chewable tablets 24 tablet VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
Aluminium hydroxide 500mg / Dimeticone 270mg chewable tablets 24 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Aluminium hydroxide 500mg / Dimeticone 270mg chewable tablets 24 tablet Has manufactured dose form Conventional release chewable tablet false Inferred relationship Existential restriction modifier
Aluminium hydroxide 500mg / Dimeticone 270mg chewable tablets 24 tablet Has VMP Aluminium hydroxide 500mg / Dimeticone 270mg chewable tablets true Inferred relationship Existential restriction modifier
Aluminium hydroxide 500mg / Dimeticone 270mg chewable tablets 24 tablet Has specific active ingredient Simeticone true Inferred relationship Existential restriction modifier
Aluminium hydroxide 500mg / Dimeticone 270mg chewable tablets 24 tablet Has specific active ingredient Aluminium hydroxide gel dried true Inferred relationship Existential restriction modifier
Aluminium hydroxide 500mg / Dimeticone 270mg chewable tablets 24 tablet Has dispensed dose form Conventional release chewable tablet true Inferred relationship Existential restriction modifier
Aluminium hydroxide 500mg / Dimeticone 270mg chewable tablets 24 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Asilone Antacid chewable tablets (Thornton & Ross Ltd) 24 tablet Is a True Aluminium hydroxide 500mg / Dimeticone 270mg chewable tablets 24 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start